☰

Monte M. Winslow - Publications

Affiliations: 
Stanford University, Palo Alto, CA 
Area:
Genetics
Tree Info Grants Similar researchers PubMed Report error

91 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Blair LM, Juan JM, Sebastian L, Tran VB, Nie W, Wall GD, Gerceker M, Lai IK, Apilado EA, Grenot G, Amar D, Foggetti G, Do Carmo M, Ugur Z, Deng D, ... ... Winslow MM, et al. Oncogenic context shapes the fitness landscape of tumor suppression. Nature Communications. 14: 6422. PMID 37828026 DOI: 10.1038/s41467-023-42156-y  0.554
2023 Yousefi M, Andrejka L, Szamecz M, Winslow MM, Petrov DA, Boross G. Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma. Proceedings of the National Academy of Sciences of the United States of America. 120: e2303224120. PMID 37695905 DOI: 10.1073/pnas.2303224120  0.554
2023 Gonzalez MA, Lu DR, Yousefi M, Kroll A, Lo CH, Briseño CG, Watson JEV, Novitskiy S, Arias V, Zhou H, Plata Stapper A, Tsai MK, Ashkin EL, Murray CW, Li CM, ... Winslow MM, et al. Phagocytosis increases an oxidative metabolic and immune suppressive signature in tumor macrophages. The Journal of Experimental Medicine. 220. PMID 36995340 DOI: 10.1084/jem.20221472  0.315
2023 Yousefi M, Andrejka L, Winslow MM, Petrov DA, Boross G. Fully accessible fitness landscape of oncogene-negative lung adenocarcinoma. Biorxiv : the Preprint Server For Biology. PMID 36778226 DOI: 10.1101/2023.01.30.526178  0.55
2023 Lee MC, Cai H, Murray CW, Li C, Shue YT, Andrejka L, He AL, Holzem AME, Drainas AP, Ko JH, Coles GL, Kong C, Zhu S, Zhu C, Wang J, ... ... Winslow MM, et al. A multiplexed in vivo approach to identify driver genes in small cell lung cancer. Cell Reports. 42: 111990. PMID 36640300 DOI: 10.1016/j.celrep.2023.111990  0.591
2023 Tang R, Shuldiner EG, Kelly M, Murray CW, Hebert JD, Andrejka L, Tsai MK, Hughes NW, Parker MI, Cai H, Li YC, Wahl GM, Dunbrack RL, Jackson PK, Petrov DA, ... Winslow MM, et al. Multiplexed screens identify RAS paralogues HRAS and NRAS as suppressors of KRAS-driven lung cancer growth. Nature Cell Biology. PMID 36635501 DOI: 10.1038/s41556-022-01049-w  0.519
2022 Yousefi M, Boross G, Weiss C, Murray CW, Hebert JD, Cai H, Ashkin EL, Karmakar S, Andrejka L, Chen L, Wang M, Tsai MK, Lin WY, Li C, Yakhchalian P, ... ... Winslow MM, et al. Combinatorial Inactivation of Tumor Suppressors Efficiently Initiates Lung Adenocarcinoma with Therapeutic Vulnerabilities. Cancer Research. 82: 1589-1602. PMID 35425962 DOI: 10.1158/0008-5472.CAN-22-0059  0.566
2022 Foggetti G, Li C, Cai H, Petrov DA, Winslow MM, Politi K. Tumor suppressor pathways shape EGFR-driven lung tumor progression and response to treatment. Molecular & Cellular Oncology. 9: 1994328. PMID 35252550 DOI: 10.1080/23723556.2021.1994328  0.54
2022 Murray CW, Brady JJ, Han M, Cai H, Tsai MK, Pierce SE, Cheng R, Demeter J, Feldser DM, Jackson PK, Shackelford DB, Winslow MM. LKB1 drives stasis and C/EBP-mediated reprogramming to an alveolar type II fate in lung cancer. Nature Communications. 13: 1090. PMID 35228570 DOI: 10.1038/s41467-022-28619-8  0.336
2021 Dorsch M, Kowalczyk M, Planque M, Heilmann G, Urban S, Dujardin P, Forster J, Ueffing K, Nothdurft S, Oeck S, Paul A, Liffers ST, Kaschani F, Kaiser M, Schramm A, ... ... Winslow MM, et al. Statins affect cancer cell plasticity with distinct consequences for tumor progression and metastasis. Cell Reports. 37: 110056. PMID 34818551 DOI: 10.1016/j.celrep.2021.110056  0.307
2021 Pierce SE, Granja JM, Corces MR, Brady JJ, Tsai MK, Pierce AB, Tang R, Chu P, Feldser DM, Chang HY, Bassik MC, Greenleaf WJ, Winslow MM. LKB1 inactivation modulates chromatin accessibility to drive metastatic progression. Nature Cell Biology. PMID 34341533 DOI: 10.1038/s41556-021-00728-4  0.302
2021 Xue B, Chuang CH, Prosser HM, Fuziwara CS, Chan C, Sahasrabudhe N, Kühn M, Wu Y, Chen J, Biton A, Chen C, Wilkinson JE, McManus MT, Bradley A, Winslow MM, et al. deficiency promotes lung cancer metastasis by activating Notch signaling in cancer-associated fibroblasts. Genes & Development. PMID 34301766 DOI: 10.1101/gad.347344.120  0.314
2021 Li C, Lin WY, Rizvi H, Cai H, McFarland CD, Rogers ZN, Yousefi M, Winters IP, Rudin CM, Petrov DA, Winslow MM. Quantitative in vivo analyses reveal a complex pharmacogenomic landscape in lung adenocarcinoma. Cancer Research. PMID 34215621 DOI: 10.1158/0008-5472.CAN-21-0716  0.762
2021 Chaikovsky AC, Li C, Jeng EE, Loebell S, Lee MC, Murray CW, Cheng R, Demeter J, Swaney DL, Chen SH, Newton BW, Johnson JR, Drainas AP, Shue YT, Seoane JA, ... ... Winslow MM, et al. The AMBRA1 E3 ligase adaptor regulates the stability of cyclin D. Nature. PMID 33854239 DOI: 10.1038/s41586-021-03474-7  0.479
2021 Foggetti G, Li C, Cai H, Hellyer JA, Lin WY, Ayeni D, Hastings K, Choi J, Wurtz A, Andrejka L, Maghini DG, Rashleigh N, Levy S, Homer R, Gettinger SN, ... ... Winslow MM, et al. Genetic determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response In Vivo. Cancer Discovery. PMID 33707235 DOI: 10.1158/2159-8290.CD-20-1385  0.522
2021 Cai H, Chew SK, Li C, Tsai MK, Andrejka L, Murray CW, Hughes NW, Shuldiner EG, Ashkin EL, Tang R, Hung KL, Chen LC, Lee SYC, Yousefi M, Lin WY, ... ... Winslow MM, et al. A functional taxonomy of tumor suppression in oncogenic KRAS-driven lung cancer. Cancer Discovery. PMID 33608386 DOI: 10.1158/2159-8290.CD-20-1325  0.781
2020 Ko J, Winslow MM, Sage J. Mechanisms of small cell lung cancer metastasis. Embo Molecular Medicine. e13122. PMID 33296145 DOI: 10.15252/emmm.202013122  0.319
2020 Chuang CH, Dorsch M, Dujardin P, Silas S, Ueffing K, Hölken JM, Yang D, Winslow MM, Grüner BM. Altered mitochondria functionality defines a metastatic cell state in lung cancer and creates an exploitable vulnerability. Cancer Research. PMID 33239425 DOI: 10.1158/0008-5472.CAN-20-1865  0.321
2020 Han K, Pierce SE, Li A, Spees K, Anderson GR, Seoane JA, Lo YH, Dubreuil M, Olivas M, Kamber RA, Wainberg M, Kostyrko K, Kelly MR, Yousefi M, Simpkins SW, ... ... Winslow MM, et al. CRISPR screens in cancer spheroids identify 3D growth-specific vulnerabilities. Nature. 580: 136-141. PMID 32238925 DOI: 10.1038/S41586-020-2099-X  0.57
2020 Cai H, Li C, Chew SK, Yousefi M, Foggetti G, Lin W, Rogers ZN, Winters IP, McFarland CD, Politi K, Swanton C, Petrov DA, Winslow MM. Abstract IA26: Multiplexed functional cancer genomics Cancer Research. 80. DOI: 10.1158/1538-7445.Camodels2020-Ia26  0.771
2020 Foggetti G, Li C, Cai H, Lin W, Ayeni D, Hastings K, Andrejka L, Maghini D, Homer R, Petrov DA, Winslow MM, Politi K. Abstract 1094: Genetic determinants of EGFR-driven lung cancer growth and therapeutic response in vivo Cancer Research. 80: 1094-1094. DOI: 10.1158/1538-7445.Am2020-1094  0.439
2019 Yang D, Qu F, Cai H, Chuang CH, Lim JS, Jahchan N, Grüner BM, S Kuo C, Kong C, Oudin MJ, Winslow MM, Sage J. Axon-like protrusions promote small cell lung cancer migration and metastasis. Elife. 8. PMID 31833833 DOI: 10.7554/Elife.50616  0.356
2019 Murray CW, Brady JJ, Tsai MK, Li C, Winters IP, Tang R, Andrejka L, Ma RK, Kunder CA, Chu P, Winslow MM. An Lkb1-Sik axis suppresses lung tumor growth and controls differentiation. Cancer Discovery. PMID 31350327 DOI: 10.1158/2159-8290.Cd-18-1237  0.458
2019 Yang D, Qu F, Cai H, Chuang C, Lim JS, Jahchan N, Grüner BM, Kuo CS, Kong C, Oudin MJ, Winslow MM, Sage J. Author response: Axon-like protrusions promote small cell lung cancer migration and metastasis Elife. DOI: 10.7554/Elife.50616.Sa2  0.341
2018 Winters IP, Murray CW, Winslow MM. Towards quantitative and multiplexed in vivo functional cancer genomics. Nature Reviews. Genetics. PMID 30267031 DOI: 10.1038/S41576-018-0053-7  0.378
2018 Chiou SH, Dorsch M, Kusch E, Naranjo S, Kozak MM, Koong AC, Winslow MM, Grüner BM. Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance. Scientific Reports. 8: 14008. PMID 30228296 DOI: 10.1038/S41598-018-32159-X  0.355
2018 Yang D, Denny SK, Greenside PG, Chaikovsky AC, Brady JJ, Ouadah Y, Granja JM, Jahchan NS, Lim JS, Kwok S, Kong CS, Berghoff AS, Schmitt A, Reinhardt HC, Park KS, ... ... Winslow MM, et al. Intertumoral Heterogeneity in SCLC Is Influenced by the Cell Type of Origin. Cancer Discovery. PMID 30228179 DOI: 10.1158/2159-8290.Cd-17-0987  0.434
2018 Caswell DR, Chuang CH, Ma RK, Winters IP, Snyder EL, Winslow MM. Tumor Suppressor Activity of Selenbp1, a Direct Nkx2-1 Target, in Lung Adenocarcinoma. Molecular Cancer Research : McR. PMID 30002193 DOI: 10.1158/1541-7786.Mcr-18-0392  0.414
2018 Rogers ZN, McFarland CD, Winters IP, Seoane JA, Brady JJ, Yoon S, Curtis C, Petrov DA, Winslow MM. Mapping the in vivo fitness landscape of lung adenocarcinoma tumor suppression in mice. Nature Genetics. PMID 29610476 DOI: 10.1038/S41588-018-0083-2  0.786
2018 Yang D, Winslow MM, Sage J. Abstract IA07: Influence of cancer initiation on tumor progression in SCLC Clinical Cancer Research. 24. DOI: 10.1158/1557-3265.Aacriaslc18-Ia07  0.464
2018 Winters IP, Rogers ZN, McFarland CD, Lalgudi PV, Chiou S, Kay MA, Petrov D, Winslow MM. Abstract IA03: Functional lung cancer genomics through in vivo genome editing Clinical Cancer Research. 24. DOI: 10.1158/1557-3265.Aacriaslc18-Ia03  0.792
2018 Lim JS, Yang D, Shue YT, Winslow M, Sage J. Abstract IA12: Intra- and intertumoral heterogeneity and response to therapy in mouse models of SCLC Cancer Research. 78. DOI: 10.1158/1538-7445.Mousemodels17-Ia12  0.473
2017 Winters IP, Chiou SH, Paulk NK, McFarland CD, Lalgudi PV, Ma RK, Lisowski L, Connolly AJ, Petrov DA, Kay MA, Winslow MM. Multiplexed in vivo homology-directed repair and tumor barcoding enables parallel quantification of Kras variant oncogenicity. Nature Communications. 8: 2053. PMID 29233960 DOI: 10.1038/S41467-017-01519-Y  0.787
2017 Chiou SH, Risca VI, Wang GX, Yang D, Grüner BM, Kathiria AS, Ma RK, Vaka D, Chu P, Kozak M, Castellini L, Graves EE, Kim GE, Mourrain P, Koong AC, ... ... Winslow MM, et al. Blimp1 induces transient metastatic heterogeneity in pancreatic cancer. Cancer Discovery. PMID 28790031 DOI: 10.1158/2159-8290.Cd-17-0250  0.39
2017 Gocheva V, Naba A, Bhutkar A, Guardia T, Miller KM, Li CM, Dayton TL, Sanchez-Rivera FJ, Kim-Kiselak C, Jailkhani N, Winslow MM, Del Rosario A, Hynes RO, Jacks T. Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival. Proceedings of the National Academy of Sciences of the United States of America. PMID 28652369 DOI: 10.1073/Pnas.1707054114  0.424
2017 Rogers ZN, McFarland CD, Winters IP, Naranjo S, Chuang CH, Petrov D, Winslow MM. A quantitative and multiplexed approach to uncover the fitness landscape of tumor suppression in vivo. Nature Methods. PMID 28530655 DOI: 10.1038/Nmeth.4297  0.783
2017 Chuang CH, Greenside PG, Rogers ZN, Brady JJ, Yang D, Ma RK, Caswell DR, Chiou SH, Winters AF, Grüner BM, Ramaswami G, Spencley AL, Kopecky KE, Sayles LC, Sweet-Cordero EA, ... ... Winslow MM, et al. Molecular definition of a metastatic lung cancer state reveals a targetable CD109-Janus kinase-Stat axis. Nature Medicine. PMID 28191885 DOI: 10.1038/Nm.4285  0.447
2016 Grüner BM, Schulze CJ, Yang D, Ogasawara D, Dix MM, Rogers ZN, Chuang CH, McFarland CD, Chiou SH, Brown JM, Cravatt BF, Bogyo M, Winslow MM. An in vivo multiplexed small-molecule screening platform. Nature Methods. PMID 27617390 DOI: 10.1038/Nmeth.3992  0.713
2016 Denny SK, Yang D, Chuang CH, Brady JJ, Lim JS, Grüner BM, Chiou SH, Schep AN, Baral J, Hamard C, Antoine M, Wislez M, Kong CS, Connolly AJ, Park KS, ... ... Winslow MM, et al. Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility. Cell. PMID 27374332 DOI: 10.1016/J.Cell.2016.05.052  0.424
2016 Weiskopf K, Jahchan NS, Schnorr PJ, Cristea S, Ring AM, Maute RL, Volkmer AK, Volkmer JP, Liu J, Lim JS, Yang D, Seitz G, Nguyen T, Wu D, Jude K, ... ... Winslow MM, et al. CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer. The Journal of Clinical Investigation. PMID 27294525 DOI: 10.1172/Jci81603  0.339
2016 Brady JJ, Chuang CH, Greenside PG, Rogers ZN, Murray CW, Caswell DR, Hartmann U, Connolly AJ, Sweet-Cordero EA, Kundaje A, Winslow MM. An Arntl2-Driven Secretome Enables Lung Adenocarcinoma Metastatic Self-Sufficiency. Cancer Cell. PMID 27150038 DOI: 10.1016/J.Ccell.2016.03.003  0.42
2016 Chatterji P, Hamilton K, Andres S, Mizuno R, Hicks P, Jeganathan A, Winslow MM, Castells A, Cuatrecasas M, Madison B, Rustgi A. Abstract 1136: Cooperative functional roles of RNA binding proteins LIN28B and IMP1 in the pathogenesis of colorectal cancer Cancer Research. 76: 1136-1136. DOI: 10.1158/1538-7445.Am2016-1136  0.374
2015 Robles-Oteiza C, Taylor S, Yates T, Cicchini M, Lauderback B, Cashman CR, Burds AA, Winslow MM, Jacks T, Feldser DM. Recombinase-based conditional and reversible gene regulation via XTR alleles. Nature Communications. 6: 8783. PMID 26537451 DOI: 10.1038/Ncomms9783  0.303
2015 Madison BB, Jeganathan AN, Mizuno R, Winslow MM, Castells A, Cuatrecasas M, Rustgi AK. Let-7 Represses Carcinogenesis and a Stem Cell Phenotype in the Intestine via Regulation of Hmga2. Plos Genetics. 11: e1005408. PMID 26244988 DOI: 10.1371/Journal.Pgen.1005408  0.308
2015 Chiou SH, Winters IP, Wang J, Naranjo S, Dudgeon C, Tamburini FB, Brady JJ, Yang D, Grüner BM, Chuang CH, Caswell DR, Zeng H, Chu P, Kim GE, Carpizo DR, ... ... Winslow MM, et al. Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing. Genes & Development. PMID 26178787 DOI: 10.1101/Gad.264861.115  0.397
2015 Kumar MS, Armenteros-Monterroso E, East P, Chakravorty P, Matthews N, Winslow MM, Downward J. Retraction: HMGA2 functions as a competing endogenous RNA to promote lung cancer progression. Nature. 523: 370. PMID 26061768 DOI: 10.1038/Nature14551  0.317
2015 Ofori LO, Withana NP, Prestwood TR, Verdoes M, Brady JJ, Winslow MM, Sorger J, Bogyo M. Design of Protease Activated Optical Contrast Agents That Exploit a Latent Lysosomotropic Effect for Use in Fluorescence-Guided Surgery. Acs Chemical Biology. 10: 1977-88. PMID 26039341 DOI: 10.1021/Acschembio.5B00205  0.373
2015 Valdmanis PN, Roy-Chaudhuri B, Kim HK, Sayles LC, Zheng Y, Chuang CH, Caswell DR, Chu K, Zhang Y, Winslow MM, Sweet-Cordero EA, Kay MA. Upregulation of the microRNA cluster at the Dlk1-Dio3 locus in lung adenocarcinoma. Oncogene. 34: 94-103. PMID 24317514 DOI: 10.1038/onc.2013.523  0.342
2015 Chiou S, Winslow M. Abstract A20: Molecular dissection of pancreatic cancer invasion and metastasis Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-A20  0.414
2015 Brady JJ, Chuang C, Caswell DR, Winslow MM. Abstract 2255: Mechanisms governing lung adenocarcinoma metastasis Cancer Research. 75: 2255-2255. DOI: 10.1158/1538-7445.Am2015-2255  0.461
2014 Goodwin JM, Svensson RU, Lou HJ, Winslow MM, Turk BE, Shaw RJ. An AMPK-independent signaling pathway downstream of the LKB1 tumor suppressor controls Snail1 and metastatic potential. Molecular Cell. 55: 436-50. PMID 25042806 DOI: 10.1016/J.Molcel.2014.06.021  0.407
2014 Sinkevicius KW, Kriegel C, Bellaria KJ, Lee J, Lau AN, Leeman KT, Zhou P, Beede AM, Fillmore CM, Caswell D, Barrios J, Wong KK, Sholl LM, Schlaeger TM, Bronson RT, ... ... Winslow MM, et al. Neurotrophin receptor TrkB promotes lung adenocarcinoma metastasis. Proceedings of the National Academy of Sciences of the United States of America. 111: 10299-304. PMID 24982195 DOI: 10.1073/Pnas.1404399111  0.431
2014 Caswell DR, Chuang CH, Yang D, Chiou SH, Cheemalavagu S, Kim-Kiselak C, Connolly A, Winslow MM. Obligate progression precedes lung adenocarcinoma dissemination. Cancer Discovery. 4: 781-9. PMID 24740995 DOI: 10.1158/2159-8290.Cd-13-0862  0.433
2014 Kumar MS, Armenteros-Monterroso E, East P, Chakravorty P, Matthews N, Winslow MM, Downward J. HMGA2 functions as a competing endogenous RNA to promote lung cancer progression. Nature. 505: 212-7. PMID 24305048 DOI: 10.1038/Nature12785  0.397
2013 Li CM, Chen G, Dayton TL, Kim-Kiselak C, Hoersch S, Whittaker CA, Bronson RT, Beer DG, Winslow MM, Jacks T. Differential Tks5 isoform expression contributes to metastatic invasion of lung adenocarcinoma. Genes & Development. 27: 1557-67. PMID 23873940 DOI: 10.1101/Gad.222745.113  0.422
2013 Byun S, Son S, Amodei D, Cermak N, Shaw J, Kang JH, Hecht VC, Winslow MM, Jacks T, Mallick P, Manalis SR. Characterizing deformability and surface friction of cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 110: 7580-5. PMID 23610435 DOI: 10.1073/Pnas.1218806110  0.321
2013 Goodwin JM, Svensson RU, Shackelford DB, Winslow MM, Shaw RJ. Abstract A59: Dixdc1 links the LKB1 tumor suppressor to Snail, noncanonical Wnt signaling, and metastasis Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-A59  0.463
2013 Li CM, Chen G, Dayton T, Kim-Kiselak C, Beer D, Winslow M, Jacks T. Abstract C22: Differential Tks5 isoform expression contributes to metastatic invasion of lung adenocarcinoma Cancer Research. 73. DOI: 10.1158/1538-7445.Fbcr13-C22  0.403
2013 Gruener BM, Chuang C, Linde I, Chiou S, Readhead B, Dudley J, Doench J, Root D, Winslow MM. Abstract B230: Targeting mitochondria for metastatic lung adenocarcinoma specific lethality. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-B230  0.448
2013 Kumar MS, Armenteros-Monterroso E, East P, Chakravorty P, Matthews N, Winslow MM, Downward J. Abstract B221: Hmga2 furthers lung adenocarcinoma progression through function as a competing endogenous RNA. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-B221  0.4
2012 Reticker-Flynn NE, Malta DF, Winslow MM, Lamar JM, Xu MJ, Underhill GH, Hynes RO, Jacks TE, Bhatia SN. A combinatorial extracellular matrix platform identifies cell-extracellular matrix interactions that correlate with metastasis. Nature Communications. 3: 1122. PMID 23047680 DOI: 10.1038/Ncomms2128  0.311
2012 Runkle EA, Rice SJ, Qi J, Masser D, Antonetti DA, Winslow MM, Mu D. Occludin is a direct target of thyroid transcription factor-1 (TTF-1/NKX2-1). The Journal of Biological Chemistry. 287: 28790-801. PMID 22761434 DOI: 10.1074/Jbc.M112.367987  0.417
2012 Schroeder A, Heller DA, Winslow MM, Dahlman JE, Pratt GW, Langer R, Jacks T, Anderson DG. Treating metastatic cancer with nanotechnology. Nature Reviews. Cancer. 12: 39-50. PMID 22193407 DOI: 10.1038/Nrc3180  0.339
2012 Reticker-Flynn NE, Malta DFB, Winslow MM, Xu MJ, Lamar JM, Hynes RO, Jacks TE, Bhatia SN. Abstract 2973: Adhesion of tumor cells to ECM microarrays identifies novel ECM interactions in metastasis Cancer Research. 72: 2973-2973. DOI: 10.1158/1538-7445.Am2012-2973  0.435
2011 Xue W, Meylan E, Oliver TG, Feldser DM, Winslow MM, Bronson R, Jacks T. Response and resistance to NF-κB inhibitors in mouse models of lung adenocarcinoma. Cancer Discovery. 1: 236-47. PMID 21874163 DOI: 10.1158/2159-8290.Cd-11-0073  0.411
2011 Dooley AL, Winslow MM, Chiang DY, Banerji S, Stransky N, Dayton TL, Snyder EL, Senna S, Whittaker CA, Bronson RT, Crowley D, Barretina J, Garraway L, Meyerson M, Jacks T. Nuclear factor I/B is an oncogene in small cell lung cancer. Genes & Development. 25: 1470-5. PMID 21764851 DOI: 10.1101/Gad.2046711  0.428
2011 Shaw AT, Winslow MM, Magendantz M, Ouyang C, Dowdle J, Subramanian A, Lewis TA, Maglathin RL, Tolliday N, Jacks T. Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stress. Proceedings of the National Academy of Sciences of the United States of America. 108: 8773-8. PMID 21555567 DOI: 10.1073/Pnas.1105941108  0.325
2011 Winslow MM, Dayton TL, Verhaak RG, Kim-Kiselak C, Snyder EL, Feldser DM, Hubbard DD, DuPage MJ, Whittaker CA, Hoersch S, Yoon S, Crowley D, Bronson RT, Chiang DY, Meyerson M, et al. Suppression of lung adenocarcinoma progression by Nkx2-1. Nature. 473: 101-4. PMID 21471965 DOI: 10.1038/Nature09881  0.4
2011 DuPage M, Cheung AF, Mazumdar C, Winslow MM, Bronson R, Schmidt LM, Crowley D, Chen J, Jacks T. Endogenous T cell responses to antigens expressed in lung adenocarcinomas delay malignant tumor progression. Cancer Cell. 19: 72-85. PMID 21251614 DOI: 10.1016/J.Ccr.2010.11.011  0.426
2011 Blat IC, Winslow MM, Jacks TE. Abstract B148: The miRNA-200 family regulates cell migration and metastasis in lung adenocarcinoma. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-B148  0.335
2010 Feldser DM, Kostova KK, Winslow MM, Taylor SE, Cashman C, Whittaker CA, Sanchez-Rivera FJ, Resnick R, Bronson R, Hemann MT, Jacks T. Stage-specific sensitivity to p53 restoration during lung cancer progression. Nature. 468: 572-5. PMID 21107428 DOI: 10.1038/Nature09535  0.373
2010 DuPage M, Cheung AF, Mazumdar C, Winslow MM, Bronson RT, Crowley D, Jacks T. Abstract LB-330: Endogenous T cell responses to lung adenocarcinoma neoantigens delay malignant tumor progression Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-330  0.44
2010 McFadden DG, Xuan Z, Rosebrock A, Politi K, Santiago P, Hodges E, Winslow M, Hiramatsu N, Pirun M, Crowley D, Bronson R, Socci N, Varmus H, Hannon G, Jacks T. Abstract LB-151: Targeted gene resequencing in a K-ras-dependent mouse model of metastatic lung adenocarcinoma Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-151  0.45
2010 Dooley AL, Winslow MM, Chiang D, Banerji S, Whittaker C, Bronson R, Crowley D, Meyerson M, Jacks T. Abstract LB-146: Identification of copy number alterations in small cell lung cancer Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-146  0.471
2009 Winslow MM, Dayton TL, Snyder EL, Chiang DY, Kim C, Verhaak R, Crowley D, Bronson RT, Meyerson M, Jacks TE. Abstract B39: Nkx2-1 down-regulation underlies lung adenocarcinoma progression towards malignancy Cancer Research. 69. DOI: 10.1158/0008-5472.Fbcr09-B39  0.339
2008 Li DH, Winslow MM, Cao TM, Chen AH, Davis CR, Mellins ED, Utz PJ, Crabtree GR, Parnes JR. Modulation of peripheral B cell tolerance by CD72 in a murine model. Arthritis and Rheumatism. 58: 3192-204. PMID 18821699 DOI: 10.1002/Art.23812  0.638
2008 Gallo EM, Ho L, Winslow MM, Staton TL, Crabtree GR. Selective role of calcineurin in haematopoiesis and lymphopoiesis. Embo Reports. 9: 1141-8. PMID 18818667 DOI: 10.1038/Embor.2008.174  0.715
2007 Gallo EM, Winslow MM, Canté-Barrett K, Radermacher AN, Ho L, McGinnis L, Iritani B, Neilson JR, Crabtree GR. Calcineurin sets the bandwidth for discrimination of signals during thymocyte development. Nature. 450: 731-5. PMID 18046413 DOI: 10.1038/Nature06305  0.691
2007 Lessard J, Wu JI, Ranish JA, Wan M, Winslow MM, Staahl BT, Wu H, Aebersold R, Graef IA, Crabtree GR. An essential switch in subunit composition of a chromatin remodeling complex during neural development. Neuron. 55: 201-15. PMID 17640523 DOI: 10.1016/J.Neuron.2007.06.019  0.743
2007 Canté-Barrett K, Winslow MM, Crabtree GR. Selective role of NFATc3 in positive selection of thymocytes. Journal of Immunology (Baltimore, Md. : 1950). 179: 103-10. PMID 17579027 DOI: 10.4049/Jimmunol.179.1.103  0.552
2007 Pan M, Winslow MM, Chen L, Kuo A, Felsher D, Crabtree GR. Enhanced NFATc1 nuclear occupancy causes T cell activation independent of CD28 costimulation. Journal of Immunology (Baltimore, Md. : 1950). 178: 4315-21. PMID 17371988 DOI: 10.4049/Jimmunol.178.7.4315  0.509
2007 Pan M, Winslow MM, Keum JS, Crabtree GR. Stringent control of NFATc1 nuclear occupancy is critical for maintaining balanced immune response Gene Therapy and Molecular Biology. 11: 171-176.  0.36
2006 Heit JJ, Apelqvist AA, Gu X, Winslow MM, Neilson JR, Crabtree GR, Kim SK. Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function. Nature. 443: 345-9. PMID 16988714 DOI: 10.1038/Nature05097  0.668
2006 Winslow MM, Pan M, Starbuck M, Gallo EM, Deng L, Karsenty G, Crabtree GR. Calcineurin/NFAT signaling in osteoblasts regulates bone mass. Developmental Cell. 10: 771-82. PMID 16740479 DOI: 10.1016/J.Devcel.2006.04.006  0.668
2006 Arron JR, Winslow MM, Polleri A, Chang CP, Wu H, Gao X, Neilson JR, Chen L, Heit JJ, Kim SK, Yamasaki N, Miyakawa T, Francke U, Graef IA, Crabtree GR. NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature. 441: 595-600. PMID 16554754 DOI: 10.1038/Nature04678  0.749
2006 Winslow MM, Gallo EM, Neilson JR, Crabtree GR. The calcineurin phosphatase complex modulates immunogenic B cell responses. Immunity. 24: 141-52. PMID 16473827 DOI: 10.1016/J.Immuni.2005.12.013  0.756
2006 Canté-Barrett K, Gallo EM, Winslow MM, Crabtree GR. Thymocyte negative selection is mediated by protein kinase C- and Ca2+-dependent transcriptional induction of bim [corrected]. Journal of Immunology (Baltimore, Md. : 1950). 176: 2299-306. PMID 16455986 DOI: 10.4049/Jimmunol.176.4.2299  0.715
2006 Polleri A, Graef IA, Arron JR, Winslow MM, Kim SK, Miyakawa T, Francke U, Crabtree GR. Increased dosage of DSCR1 and DYRK1A on chromosome 21 destabilizes NFAT regulation and accounts for Down syndrome phenotypes Developmental Biology. 295: 324. DOI: 10.1016/J.Ydbio.2006.04.007  0.444
2005 Winslow MM, Crabtree GR. Immunology. Decoding calcium signaling. Science (New York, N.Y.). 307: 56-7. PMID 15637261 DOI: 10.1126/Science.1108163  0.463
2004 Neilson JR, Winslow MM, Hur EM, Crabtree GR. Calcineurin B1 is essential for positive but not negative selection during thymocyte development. Immunity. 20: 255-66. PMID 15030770 DOI: 10.1016/S1074-7613(04)00052-4  0.698
2003 Winslow MM, Neilson JR, Crabtree GR. Calcium signalling in lymphocytes. Current Opinion in Immunology. 15: 299-307. PMID 12787755 DOI: 10.1016/S0952-7915(03)00050-5  0.648
Show low-probability matches.